These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14969629)

  • 1. Impact of strut thickness on late luminal loss after coronary artery stent placement.
    Rittersma SZ; de Winter RJ; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Tijssen JG; Piek JJ
    Am J Cardiol; 2004 Feb; 93(4):477-80. PubMed ID: 14969629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].
    Kastrati A; Mehilli J; Dirschinger J; Dotzer F; Schuhlen H; Neumann FJ; Fleckenstein M; Pfafferott C; Seyfarth M; Schomig A
    Vestn Rentgenol Radiol; 2012; (2):52-60. PubMed ID: 22730760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pathology: radiation-induced coronary artery disease in man and animals.
    Virmani R; Farb A; Carter AJ; Jones RM
    Semin Interv Cardiol; 1998; 3(3-4):163-72. PubMed ID: 10406688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial.
    Pache J; Dibra A; Mehilli J; Dirschinger J; Schömig A; Kastrati A
    Eur Heart J; 2005 Jul; 26(13):1262-8. PubMed ID: 15737962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.
    Ellis SG; Popma JJ; Lasala JM; Koglin JJ; Cox DA; Hermiller J; O'shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Stone GW
    J Am Coll Cardiol; 2005 Apr; 45(8):1193-200. PubMed ID: 15837248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
    Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.
    Lansky AJ; Costa RA; Mooney M; Midei MG; Lui HK; Strickland W; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1180-5. PubMed ID: 15837246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral rapamycin to prevent human coronary stent restenosis: a pilot study.
    Guarda E; Marchant E; Fajuri A; Martínez A; Morán S; Mendez M; Uriarte P; Valenzuela E; Lazen R
    Am Heart J; 2004 Aug; 148(2):e9. PubMed ID: 15309012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions.
    Lee CW; Park KH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):918-22. PubMed ID: 16996874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
    Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.
    Tan HC; Lim YT; Rosli TL; Sim KH; Tan KH; Lee CH; Ismail O; Azman W
    Am Heart J; 2004 Dec; 148(6):1007-11. PubMed ID: 15632886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: the Asian Pacific Multicenter Arthos Stent Study (PASS) trial.
    Kim YH; Lee CW; Hong MK; Park SW; Tahk SJ; Yang JY; Saito S; Santoso T; Quan L; Ge J; Weissman NJ; Lansky AJ; Mintz GS; Park SJ
    Am Heart J; 2005 Feb; 149(2):336-41. PubMed ID: 15846274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.
    Elezi S; Dibra A; Mehilli J; Pache J; Wessely R; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Oct; 48(7):1304-9. PubMed ID: 17010786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.